Clinical Validation of a Handheld Assistive Device for Tremor (S53.005)
Citation Manager Formats
Make Comment
See Comments

Abstract
OBJECTIVE: To demonstrate the effectiveness of a handheld device on reducing tremor, using Active Cancellation of Tremor (ACT) technology.
BACKGROUND: Essential Tremor (ET) causes action tremors that can severely limit a person's ability to eat, resulting in decreased quality of life. A compact, handheld, battery-powered device is presented that stabilizes a spoon when shaken by an unsteady hand. The device employs ACT technology to sense motion, detect whether the motion is tremor, and move the spoon to cancel tremor.
DESIGN/METHODS: Eleven subjects (9M/2F) with ET performed three tasks (holding, eating, and transferring objects) using a spoon device with ACT turned on and off. Tremor amplitude during these tasks was measured using accelerometers embedded in the device. Tremor was rated clinically by a neurologist using the Fahn-Tolosa-Marin Tremor Rating Scale, and overall improvement was rated by the subject using the Clinical Global Impression Scale (CGI-S). Both subject and neurologist were blinded to whether the device was on or off.
RESULTS: With ACT turned on, tremor amplitude was reduced by an average of 72% in the holding task, 76% in the eating task, and 71% in the transferring task as measured with the accelerometer. There was significant improvement in tremor scores with ACT on compared to ACT off in the eating (1.18 ± 0.98 vs. 0.00 ± 0.45, p=0.003) and transferring (1.18 ± 0.75 vs. 0.27 ± 0.65, p=0.006) tasks, but not the holding task. CGI-S was also significantly improved with ACT on versus ACT off with eating (2.45 ± 1.51 vs. 4.27 ± 0.47, p=0.002) and transferring (2.45 ± 1.37 vs. 3.82 ± 1.47, p=0.04).
CONCLUSIONS: The ACT assistive device can reduce tremor amplitude of a spoon when being used by individuals with ET. The tremor reduction is clinically evident and can make eating tasks easier, potentially improving an individual's quality of life.
Supported by: NIH SBIR grant 5 R44 NS 070438.
Disclosure: Dr. Pathak has received personal compensation for activities with Lynx Design. Dr. Redmond has received personal compensation for activities with Lynx Design as an employee. Dr. Allen has received personal compensation for activities with Lynx Design as a device designer. Dr. Chou has received personal compensation for activities with Medtronic, Inc., Merz Pharma, and Accordant as a consultant.
Thursday, March 21 2013, 2:00 pm-3:30 pm
- Copyright © 2013 by AAN Enterprises, Inc.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.